Gabapentin and Lac-hydrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Lac-hydrin (ammonium lactate). Common drug interactions include anxiety among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Lac-hydrin. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.

What is Lac-hydrin?

Lac-hydrin has active ingredients of ammonium lactate. eHealthMe is studying from 534 Lac-hydrin users. Check the latest studies of Lac-hydrin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

43 people who take Gabapentin and Lac-hydrin together, and have interactions are studied.

Gabapentin and Lac-hydrin drug interactions.

What are the common drug interactions of Gabapentin and Lac-Hydrin, by gender? *:

female:

Anxiety
Arteriosclerosis (thickening and hardening of arteries)
Arthropathy
Atelectasis (partial or complete collapse of the lung)
Back pain
Benign ovarian tumour
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Chest pain
Cholesteatoma (abnormal skin growth in the middle ear behind the eardrum)

male:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Injury
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Joint effusion (presence of extra fluid in joint covering)
Nephrogenic anaemia (anaemia due to kidney disease)
Pain in extremity
Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Gabapentin and Lac-Hydrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug ineffective
Dry skin
Erythema (redness of the skin)
Genotype drug resistance test positive
Hyperkeratosis (thickening of the outer layer of the skin)
Rash

30-39:

n/a

40-49:

Drug ineffective

50-59:

Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
Osteonecrosis of jaw (death of bone of jaw)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Papilloma (small, noncancerous (benign) tumour)
Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
Phlebitis (inflammation of the walls of a vein)
Pleural fibrosis (formation of fibrous tissue in lung)
Pulmonary embolism (blockage of the main artery of the lung)
Rectal haemorrhage (bleeding from anus)

60+:

Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Nephrogenic anaemia (anaemia due to kidney disease)
Pneumonia
Pyrexia (fever)
Renal failure (kidney dysfunction)
Small intestinal obstruction (blockage in small intestine)
Urinary tract infection

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 14 people, 32.56%
Pain: 8 people, 18.60%
Breast Cancer Metastatic: 5 people, 11.63%
High Blood Pressure: 4 people, 9.30%
Breast Cancer: 4 people, 9.30%
Neuropathy Peripheral (surface nerve damage): 4 people, 9.30%
Nausea (feeling of having an urge to vomit): 4 people, 9.30%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.30%
Rickets (softening of bones): 3 people, 6.98%
Constipation: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Lac-hydrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously